Traws Pharma’s COVID-19 Candidate, Ratutrelvir, Presented at ICAR
Preclinical and Phase 1 data suggest that ratutrelvir can be used without ritonavir and may reduce the likelihood of COVID rebound and the risk ...
CORT STOCK ALERT: Levi & Korsinsky Notifies Corcept Therapeutics Incorporated Investors of an Ongoing Investigation
NEW YORK, NY / ACCESS Newswire / March 25, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Corcept ...
pharmaphorum17h
Pharma’s climate change vulnerability and opportunity
As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.
Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day
The stock's rise snapped a four-day losing streak.